Stock listing

Aurinia Pharmaceuticals Inc

Selected listing: IKAP · TRADEGATE · EUR · DE

Aurinia Pharmaceuticals Inc (Tradegate:IKAP), Health Technology. Latest release Aug 6, 2026: Aurinia Pharmaceuticals Reports Financial Results for the Three…

IKAP:TRADEGATEEURDEUpdated October 2, 2026
Aurinia Pharmaceuticals Inc logo
Ticker
Tradegate:IKAP
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Tradegate
Currency
EUR

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc (Ticker: AUPH) is a public company based in the United States, focused on developing innovative therapies for kidney diseases. The company is committed to addressing unmet medical needs in the healthcare sector.

Latest news from Aurinia Pharmaceuticals Inc

All Aurinia Pharmaceuticals Inc news →

Events

Replays

  • Aurinia Pharmaceuticals Inc (AUPH) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 08:30 AM ET

    Watch
  • Aurinia Pharmaceuticals Inc (AUPH) Q3 2025 Earnings Call

    Tue, Nov 04, 2025 · 08:30 AM ET

    Watch
  • Aurinia Pharmaceuticals Inc (AUPH) Q2 2025 Earnings Call

    Thu, Jul 31, 2025 · 08:30 AM ET

    Watch

Research Aurinia Pharmaceuticals Inc

Alternate listings